Omalizumab treats multi-food allergy better than oral immunotherapy

Omalizumab treats multi-food allergy better than oral immunotherapy

News Release Monday, March 3, 2025 High rate of oral immunotherapy side effects in NIH…

Continue Reading
What to feed your baby to slash allergy risk by 45%

What to feed your baby to slash allergy risk by 45%

Food allergies now affect approximately 1 in 13 children in the US, representing an increase of…

Continue Reading
Omalizumab outperforms oral immunotherapy in treating multi-food allergy

Omalizumab outperforms oral immunotherapy in treating multi-food allergy

A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more…

Continue Reading
Jasper Therapeutics Presents Clinical and Preclinical

Jasper Therapeutics Presents Clinical and Preclinical

REDWOOD CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a…

Continue Reading
When Should I Use My Child’s EpiPen?

When Should I Use My Child’s EpiPen?

If your child has allergies, watching them experience an allergic reaction can be frightening. Parents of…

Continue Reading
Type 2 immunity in allergic diseases

Type 2 immunity in allergic diseases

Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic…

Continue Reading